Simultaneous, fast, and effective analysis of all known genes associated with a certain disease.
Understand genetic risk factors and plan health care.
Cost-effective and fast genetic analyses for well characterized clinical features.
Molecular genetic characterization of tumor tissue to aid in the selection of the best therapeutic intervention.
Parallel analysis of all coding regions of the genome.
A non-invasive prenatal test by Cenata GmbH, which can reliably detect the risk of the chromosomal disorders trisomy 21, trisomy 18, and trisomy 13.
Analysis of large deletions and duplications across the whole genome.
We’re available to support you in choosing the diagnostic strategy for individual patients and to discuss the results of the analysis.